Murine stromal cells producing hyper-interleukin-6 and Flt3 ligand support expansion of early human hematopoietic progenitor cells without need of exogenous growth factors

被引:9
作者
Keller, U
Götze, KS
Duyster, J
Schmidt, B
Rose-John, S
Peschel, C
机构
[1] Tech Univ Munich, Dept Med 3, D-81675 Munich, Germany
[2] Univ Kiel, Dept Biochem, Kiel, Germany
关键词
stromal cells; hematopoietic progenitor cells; Flt3; ligand; hyper-IL-6;
D O I
10.1038/sj.leu.2402660
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Expansion of primitive hematopoietic progenitor cells (HPC) is a major challenge in stem cell biology. Stimulation by growth factors (GF) is essential for proliferation of HPC, while the role of stromal cell coculture for maintenance of progenitor/stem cell potential is unclear. We evaluated the potential of a murine stromal cell layer providing hematopoietic GF to support expansion of human CD34(+) cells. Murine MS-5 cells were transfected with the cDNA encoding huFlt3 ligand and the interleukin6/sinterleukin-6R fusion protein hyper-IL-6. Expansion of CFC and week:6 CAFC was at least as efficient in transfected clones compared to control cocultures supported with exogenous GF. Cell numbers reached 17.5- to 62.3- (day 14) and 17.4- to 92.4-fold (day 21) of input cells. Expansion of CFU-GM/Mix was 4.0- to 12.8-fold (day 14) and 4.9- to 11.7-fold (day 21). Primitive week6 CAFC were expanded up to 6.5-fold (day 14) and 6.2-fold (day 21) without exogenous GF. When direct contact of HPC and stromal cells was inhibited, a loss of CFC and much more of CAFC potential was observed with unaffected overall cell proliferation. Here, we show the generation of GF producing murine stromal cells which efficiently support early hematopoiesis without exogenous GF. Direct stromal cell-HPC contact is advantageous for maintenance of differentiation potential.
引用
收藏
页码:2122 / 2128
页数:7
相关论文
共 31 条
[1]   Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34+CD38low/neg human bone marrow cells [J].
Bennaceur-Griscelli, A ;
Tourino, C ;
Izac, B ;
Vainchenker, W ;
Coulombel, L .
BLOOD, 1999, 94 (02) :529-538
[2]   INTERLEUKIN-6 IS REQUIRED IN-VIVO FOR THE REGULATION OF STEM-CELLS AND COMMITTED PROGENITORS OF THE HEMATOPOIETIC SYSTEM [J].
BERNAD, A ;
KOPF, M ;
KULBACKI, R ;
WEICH, N ;
KOEHLER, G ;
GUTIERREZRAMOS, JC .
IMMUNITY, 1994, 1 (09) :725-731
[3]   Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells [J].
Breems, DA ;
Blokland, EAW ;
Siebel, KE ;
Mayen, AEM ;
Engels, LJA ;
Ploemacher, RE .
BLOOD, 1998, 91 (01) :111-117
[4]   REGULATION OF HEMATOPOIESIS BY BONE-MARROW STROMAL CELLS AND THEIR PRODUCTS [J].
DORSHKIND, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :111-137
[5]  
Ebihara Y, 1997, BLOOD, V90, P4363
[6]   A bioactive designer cytokine for human hematopoietic progenitor cell expansion [J].
Fischer, M ;
Goldschmitt, J ;
Peschel, C ;
Brakenhoff, JPG ;
Kallen, KJ ;
Wollmer, A ;
Grotzinger, J ;
RoseJohn, S .
NATURE BIOTECHNOLOGY, 1997, 15 (02) :142-145
[7]   Rapid differentiation of a rare subset of adult human Lin-CD34-CD38- cells stimulated by multiple growth factors in vitro [J].
Fujisaki, T ;
Berger, MG ;
Rose-John, S ;
Eaves, CJ .
BLOOD, 1999, 94 (06) :1926-1932
[8]   gp130-Stimulating designer cytokine Hyper-interleukin-6 synergizes with murine stroma for long-term survival of primitive human hematopoietic progenitor cells [J].
Götze, KS ;
Keller, U ;
Rose-John, S ;
Peschel, C .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (07) :822-832
[9]  
Gupta P, 2000, BLOOD, V95, P147
[10]  
ITOH K, 1989, EXP HEMATOL, V17, P145